Table 2.
Author | Outcome Measure | Outcome Score |
CCD, mm |
Revisions |
Malreduction |
Complications |
---|---|---|---|---|---|---|
(SB/HP) | (SB/HP) | (SB/HP) | (SB/HP) | (SB/HP) | ||
Athar et al., 201811 | NA | NA | NA | 31.8%/42.3% | 25%/3.8% | 54.2%/32.7% |
Bin Abd Razak et al., 20184 | Constant–Murley score | 87.6/77.5∗ | 11.8/13.6 | 0%/0% | NA | 0%/30% |
VAS score | 1/1 | |||||
Jensen et al., 201412 | Constant–Murley score | 89/88 | 23.8/23.0 | 11.5%/13.3% | NA | 11.5%/13.3% |
Taft score | 10/10 | |||||
VAS score | 1.3/1.7 | |||||
Natera-Cisneros et al., 201620 | Constant–Murley score | 95.3/91.3 | NA | 5%/9.1% | 40%/36.3% | 15%/18.2% |
VAS score | 0.4/1.5∗ | |||||
Stein et al., 201813 | Constant–Murley score | 95.3/90.1∗ | 16.9/19.4 | NA | NA | NA |
Taft score | 10.9/9.4∗ | |||||
VAS score | 1.7/2.4∗ | |||||
Zhang et al., 201821 | Constant–Murley score | 95.1/85.8∗ | 7.5/7.5 | NA | NA | NA |
CCD, coracoclavicular distance; HP, hook plate; LOE, level of evidence; NA, not applicable; SB, suture button; VAS, visual analog scale.
Denotes statistically significant result.